Cassava Sciences

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$2,348
Gross Profit
-300
-311
1,992
EBITDA
-61,091
-19,623
-22,433
EBIT
-61,391
-19,934
-22,789
Net Income
6,155
25,043
-20,919
Net Change In Cash
0
0
2,348
Free Cash Flow
-18,270
-19,127
-22,357
Cash
207,291
124,169
121,136
Basic Shares
46,202
44,102
42,188

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$-1
$0
$0
Gross Profit
-89,423
-1
-534
-346
EBITDA
-95,687
-78,719
-32,334
-6,312
EBIT
-97,217
-80,020
-32,868
-6,334
Net Income
-97,217
-72,472
-31,802
-5,854
Net Change In Cash
0
-1
0
0
Cost of Revenue
139,931
70,425
Free Cash Flow
-82,439
-80,226
-52,410
-5,382
Cash
121,136
201,015
233,437
93,506
Basic Shares
41,932
40,202
39,405
26,105

Earnings Calls

Quarter EPS
2024-09-30
-$0.58
2024-06-30
$0.13
2024-03-31
$0.58
2023-12-31
-$0.50